Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;9(3):171-182.
doi: 10.1007/s13668-020-00313-5.

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry

Affiliations
Review

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry

Sabrina Mörkl et al. Curr Nutr Rep. 2020 Sep.

Erratum in

Abstract

Purpose of review: Probiotics are living bacteria, which when ingested in adequate amounts, confer health benefits. Gut microbes are suggested to play a role in many psychiatric disorders and could be a potential therapeutic target. Between the gut and the brain, there is a bi-directional communication pathway called the microbiota-gut-brain axis. The purpose of this review is to examine data from recent interventional studies focusing on probiotics and the gut-brain axis for the treatment of depression, anxiety and schizophrenia.

Recent findings: Probiotics are likely to improve depression but not schizophrenia. Regarding anxiety, there is only one trial which showed an effect of a multispecies probiotic. However, determinants like the duration of treatment, dosage and interactions have not been thoroughly investigated and deserve more scientific attention. Microbiome-based therapies such as probiotics could be cautiously recommended for depression to enhance beneficial bacteria in the gut and to improve mood through the gut-brain axis.

Keywords: Anxiety; Depression; Gut microbiota; Microbiota-gut-brain axis; Probiotics; Psychiatry; Schizophrenia; Vagal nerve.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Microbiota modulation of the central nervous system (CNS). This figure was created with BioRender.com

References

    1. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology. 2016;14(8):e1002533–e100253e. doi: 10.1371/journal.pbio.1002533. - DOI - PMC - PubMed
    1. Roger AJ, Muñoz-Gómez SA, Kamikawa R. The origin and diversification of mitochondria. Curr Biol. 2017;27(21):R1177–R1R92. doi: 10.1016/j.cub.2017.09.015. - DOI - PubMed
    1. Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF. The microbiome: stress, health and disease. Mamm Genome. 2014;25(1–2):49–74. doi: 10.1007/s00335-013-9488-5. - DOI - PubMed
    1. • Miro-Blanch J, Yanes O. Epigenetic regulation at the interplay between gut microbiota and host metabolism. Front Genet. 2019;10 This manuscript explores the importance of epigenetic regulation of host tissues by the metabolic activity of gut microbiota in response to changes in diet. - PMC - PubMed
    1. Zmora N, Soffer E, Elinav E. Transforming medicine with the microbiome. Science Translational Medicine. 2019;11(477):eaaw1815. doi: 10.1126/scitranslmed.aaw1815. - DOI - PubMed

Publication types